Literature DB >> 7142992

Age-correlated loss of dopaminergic binding sites in human basal ganglia.

J A Severson, J Marcusson, B Winblad, C E Finch.   

Abstract

Human caudate nucleus, putamen, substantia nigra, and nucleus accumbens were analyzed for the effects of age on dopaminergic binding sites. Decreases in the number of dopaminergic binding sites were detected with age in caudate nucleus (44 specimens from three sample groups) and substantia nigra (n = 12). In caudate nucleus, the decline in [3H]2-amino-6, 7-dehydroxy-1, 2, 3, 4-tetrahydronaphthalene sites was three times greater than for [3H]spiperone, but age changes were significant in only two of the three sampling groups. No age changes in binding were detected in the putamen (n = 44) or nucleus accumbens. Age, sex, and tissue source all significantly contributed to variance. However, cause of death, time from death to tissue freezing, and length of storage did not influence dopaminergic binding in the caudate nucleus or putamen. Relative to the life-span, the age-correlated decrease in dopaminergic binding sites of human brain approximates that in aging rodent striatum. Comparisons of altered dopaminergic binding with other age-correlated changes suggest that neuronal loss may not be involved in the loss of binding sites before midlife.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7142992     DOI: 10.1111/j.1471-4159.1982.tb07996.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  29 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  Dopamine and frontostriatal networks in cognitive aging.

Authors:  Ellen C Klostermann; Meredith N Braskie; Susan M Landau; James P O'Neil; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-04-20       Impact factor: 4.673

3.  Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.

Authors:  Scott E Hemby; John Q Trojanowski; Stephen D Ginsberg
Journal:  J Comp Neurol       Date:  2003-02-03       Impact factor: 3.215

4.  Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.

Authors:  David Matuskey; Patrick Worhunksy; Elizabeth Correa; Brian Pittman; Jean-Dominique Gallezot; Nabeel Nabulsi; Jim Ropchan; Venkatesh Sreeram; Rohit Gudepu; Edward Gaiser; Kelly Cosgrove; Yu-Shin Ding; Marc N Potenza; Yiyun Huang; Robert T Malison; Richard E Carson
Journal:  Neuroimage       Date:  2016-02-11       Impact factor: 6.556

5.  Age-related changes in human D1 dopamine receptors measured by positron emission tomography.

Authors:  T Suhara; H Fukuda; O Inoue; T Itoh; K Suzuki; T Yamasaki; Y Tateno
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 6.  The ageing brain: normal and abnormal memory.

Authors:  M S Albert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-11-29       Impact factor: 6.237

7.  Behavioral and metabolic characterization of heterozygous and homozygous POLG mutator mice.

Authors:  Ying Dai; Tomas Kiselak; Joanne Clark; Elizabeth Clore; Kangni Zheng; Allen Cheng; Gregory C Kujoth; Tomas A Prolla; Eleftheria Maratos-Flier; David K Simon
Journal:  Mitochondrion       Date:  2013-03-27       Impact factor: 4.160

8.  Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels.

Authors:  J C Baron; J L Martinot; H Cambon; J P Boulenger; M F Poirier; V Caillard; J Blin; J D Huret; C Loc'h; B Maziere
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Striatal dopamine D2 receptors in tardive dyskinesia: PET study.

Authors:  J Blin; J C Baron; H Cambon; A M Bonnet; B Dubois; C Loc'h; B Mazière; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

10.  Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans.

Authors:  H Toyama; M Ichise; J R Ballinger; L Fornazzari; J C Kirsh
Journal:  Ann Nucl Med       Date:  1993-02       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.